Mereo BioPharma Group Plc (MREO)

0.2901 -0.01 (-4.26%) USD  |  NASDAQ  |  Sep 21, 16:00
0.2935 0.00 (0.00%) After-Hours: 07:33
More

Mereo BioPharma Group CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical CAPEX To Revenue (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
March 31, 2026 --
December 31, 2025 --
Date Value
September 30, 2025 --
June 30, 2025 --

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc --
BioNTech SE Upgrade
Silence Therapeutics Plc Upgrade
Compass Pathways Plc --